ChemicalBook >?? ???? >N1-(4-((1,4,8,11-Tetraazacyclotetradecan-1-yl)methyl)benzyl)-N1,N3-bis(2-aminoethyl)propane-1,3-diamine
N1-(4-((1,4,8,11-Tetraazacyclotetradecan-1-yl)methyl)benzyl)-N1,N3-bis(2-aminoethyl)propane-1,3-diamine
|
|
N1-(4-((1,4,8,11-Tetraazacyclotetradecan-1-yl)methyl)benzyl)-N1,N3-bis(2-aminoethyl)propane-1,3-diamine ??
- ?? ?
- 622.0±55.0 °C(predicted)
- ??
- 1.003±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)
- ?? ?? (pKa)
- 10.30±0.20(predicted)
??
N1-(4-((1,4,8,11-Tetraazacyclotetradecan-1-yl)methyl)benzyl)-N1,N3-bis(2-aminoethyl)propane-1,3-diamine C??? ??, ??, ??
??
N1-(4-((1,4,8,11-Tetraazacyclotetradecan-1-yl)methyl)benzyl)-N1,N3-bis(2-aminoethyl)propane-1,3-diamine is a derivative of N1-[2-[(3-Aminopropyl)amino]ethyl]-N3-[[4-(1,4,8,11-tetraazacyclotetradec-1-ylmethyl)phenyl]methyl]-1,3-propanediamine (CAS# 169783-37-3), which was studied with other bis-?tetraazamacrocyclic compounds as potential HIV-1 and HIV-2 inhibitors.N1-(4-((1,4,8,11-Tetraazacyclotetradecan-1-yl)methyl)benzyl)-N1,N3-bis(2-aminoethyl)propane-1,3-diamine ?? ?? ? ???
???
?? ??
N1-(4-((1,4,8,11-Tetraazacyclotetradecan-1-yl)methyl)benzyl)-N1,N3-bis(2-aminoethyl)propane-1,3-diamine ?? ??
???( 2)?? ??
| ??? | ?? | ??? | ?? | ?? ? | ?? |
|---|---|---|---|---|---|
| Beijing Comparison Pharmaceutical Technology Co., Ltd | 010-010-52878169 15801002657 |
sales@bjcomparison.com | China | 4817 | 58 |
| Wuxi Helen Biotechnology Co., Ltd., | 0510-85629785 18013409632 |
sales@reading-chemicals.com | China | 14081 | 58 |